Quantum AI Report

The convergence of Quantum with AI

Boehringer Ingelheim

Boehringer Ingelheim is a German pharmaceutical company that explores quantum computing for drug discovery, particularly using quantum algorithms for molecular dynamics simulations. It collaborates with quantum hardware providers such as Google Quantum AI to assess the potential of near-term quantum devices for pharmaceutical research.

AI-written profile · not yet reviewed · 21 August 2026

Headquarters
Ingelheim am Rhein, Germany
Status
Private

Coverage

Sample-efficient quantum error mitigation via classical learning surrogates

A paper published in Nature Quantum Intelligence describes a method that uses classical learning surrogates to reduce the number of circuit executions needed for quantum error mitigation. The approach trains a classical model on noisy quantum circuit outputs and uses it to estimate error-mitigated expectation values more efficiently.

OutlookPlausible

The method could be integrated as an optional error mitigation layer in quantum software stacks within two years, reducing shot counts by an order of magnitude for routine VQE and QAOA experiments.

algorithms softwareBoehringer IngelheimGoogleIBMQ-CTRL